Attention-Deficit Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder (ADHD) – A Detailed Lecture

 

Introduction

 

Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity that interfere with daily functioning and development. It is one of the most common childhood psychiatric conditions and often persists into adulthood.

• Prevalence: ~5–7% of children worldwide.
• Boys > Girls (3:1 ratio).
• Onset before 12 years of age (DSM-5 criteria).
• Strong genetic and environmental influences.

Etiology (Causes)

1. Genetic Factors (Strongest Association)

• Heritability is ~75%.
• Runs in families; increased risk if a parent or sibling has ADHD.
• Genes involved: Dopamine receptor (DRD4), Dopamine transporter (DAT1).

2. Neurobiological Factors

• Dysfunction in prefrontal cortex (responsible for executive function and impulse control).
• Reduced dopamine and norepinephrine activity (affects attention and behavior regulation).

3. Environmental Risk Factors

• Prenatal exposure to smoking, alcohol, or drugs.
• Premature birth, low birth weight.
• Lead exposure, nutritional deficiencies.
• Adverse childhood experiences (neglect, abuse).

Types of ADHD (DSM-5 Classification)

1. Inattentive Type (ADHD-I)

• Difficulty focusing, easily distracted.
• Forgets tasks, poor organization skills.
• Daydreaming, careless mistakes.

2. Hyperactive-Impulsive Type (ADHD-HI)

• Excessive movement, fidgeting, restlessness.
• Interrupts conversations, talks excessively.
• Acts without thinking, difficulty waiting turn.

3. Combined Type (ADHD-C)

• Features of both inattention and hyperactivity-impulsivity.
• Most common type in children.

Clinical Features

1. Core Symptoms

• Inattention
  • Fails to pay attention to details.
  • Easily distracted by external stimuli.
  • Forgetful in daily activities.
  • Struggles with organization and time management.
• Hyperactivity
  • Fidgeting, tapping hands or feet.
  • Inability to sit still (excessive running, climbing).
  • Always “on the go,” difficulty engaging in quiet activities.
• Impulsivity
  • Interrupts conversations or activities.
  • Blurts out answers before questions are completed.
  • Difficulty waiting for a turn in games or social settings.

2. Associated Features

• Emotional dysregulation (mood swings, frustration intolerance).
• Oppositional behavior, aggression (common in ADHD with comorbid ODD).
• Sleep disturbances (difficulty falling asleep, restless sleep).
• Low self-esteem due to academic and social difficulties.

Diagnosis (Based on DSM-5 Criteria)

1. Diagnostic Criteria

• Symptoms must be present for ≥6 months.
• Onset before age 12 years.
• Symptoms occur in at least 2 settings (home, school, social).
• Symptoms cause significant impairment in daily life.
• Not better explained by another condition (e.g., anxiety, autism).

2. Clinical Assessment

• Parental and teacher reports (Vanderbilt, Conners Rating Scale).
• Observation of behavior in different settings.
• Neuropsychological testing (for executive function deficits).

3. Differential Diagnosis

• Autism Spectrum Disorder (ASD) – Social deficits, restrictive behaviors.
• Anxiety Disorders – Inattention due to excessive worry.
• Learning Disabilities – Struggles with schoolwork without hyperactivity.
• Sensory Processing Disorder – Overreacts to stimuli without impulsivity.

Management and Treatment

1. Behavioral Therapy (First-Line in Young Children)

• Parent training in behavior management (reinforcement strategies).
• Cognitive-behavioral therapy (CBT) for older children.
• Classroom modifications (seating, extra breaks, structured routine).
• Social skills training (improves peer interactions).

2. Pharmacological Treatment (First-Line in School-Age Children)

• Indicated if symptoms are moderate to severe and impair daily life.
• Two main classes:
  • Stimulants (Most Effective, First-Line)
    • Methylphenidate (Ritalin, Concerta).
    • Amphetamines (Adderall, Vyvanse).
    • Mechanism: Increases dopamine and norepinephrine in the brain.
    • Side Effects: Insomnia, decreased appetite, irritability, headache.
  • Non-Stimulants (Alternative if Stimulants Not Tolerated)
    • Atomoxetine (Strattera) – Selective norepinephrine reuptake inhibitor.
    • Guanfacine, Clonidine – Alpha-2 adrenergic agonists (help with hyperactivity, impulse control).

3. Lifestyle and Supportive Strategies

• Regular physical activity (improves focus and impulse control).
• Structured routines (predictability reduces distractions).
• Dietary modifications (ensure balanced nutrition, limit sugar/caffeine).
• Parent and teacher education (helps manage expectations).

Prognosis

• ADHD persists into adolescence in ~80% of cases.
• 30–50% continue to have symptoms into adulthood.
• Early intervention improves academic, social, and emotional outcomes.

Complications

• Academic underachievement (increased risk of school failure).
• Poor social relationships (difficulty with peers, conflict with family).
• Increased risk of accidents, injuries (impulsivity-related).
• Higher rates of substance abuse in untreated ADHD.
• Comorbid psychiatric disorders (anxiety, depression, oppositional defiant disorder).

Key Takeaways

• ADHD is a neurodevelopmental disorder affecting attention, impulse control, and activity levels.
• Symptoms must be persistent, impairing, and present in multiple settings.
• Diagnosis is clinical, using DSM-5 criteria and behavior rating scales.
• Behavioral therapy is first-line, medication is used when symptoms are severe.
• Early treatment improves long-term academic, social, and emotional outcomes.

Conclusion

ADHD is a highly prevalent but manageable condition. Multimodal treatment, including behavioral therapy, medication, and educational support, ensures optimal development and success for affected children. Parental education and structured environments play a crucial role in improving outcomes.